Cargando…
Editorial Comment to Expression of tertiary lymphoid structure in deferred cytoreductive nephrectomy of metastatic renal cell carcinoma treated with nivolumab plus ipilimumab
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560440/ https://www.ncbi.nlm.nih.gov/pubmed/34755055 http://dx.doi.org/10.1002/iju5.12360 |
| _version_ | 1784592933499961344 |
|---|---|
| author | Yuasa, Takeshi |
| author_facet | Yuasa, Takeshi |
| author_sort | Yuasa, Takeshi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8560440 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85604402021-11-08 Editorial Comment to Expression of tertiary lymphoid structure in deferred cytoreductive nephrectomy of metastatic renal cell carcinoma treated with nivolumab plus ipilimumab Yuasa, Takeshi IJU Case Rep Editorial Comment John Wiley and Sons Inc. 2021-08-17 /pmc/articles/PMC8560440/ /pubmed/34755055 http://dx.doi.org/10.1002/iju5.12360 Text en © 2021 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Urological Association https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Comment Yuasa, Takeshi Editorial Comment to Expression of tertiary lymphoid structure in deferred cytoreductive nephrectomy of metastatic renal cell carcinoma treated with nivolumab plus ipilimumab |
| title | Editorial Comment to Expression of tertiary lymphoid structure in deferred cytoreductive nephrectomy of metastatic renal cell carcinoma treated with nivolumab plus ipilimumab |
| title_full | Editorial Comment to Expression of tertiary lymphoid structure in deferred cytoreductive nephrectomy of metastatic renal cell carcinoma treated with nivolumab plus ipilimumab |
| title_fullStr | Editorial Comment to Expression of tertiary lymphoid structure in deferred cytoreductive nephrectomy of metastatic renal cell carcinoma treated with nivolumab plus ipilimumab |
| title_full_unstemmed | Editorial Comment to Expression of tertiary lymphoid structure in deferred cytoreductive nephrectomy of metastatic renal cell carcinoma treated with nivolumab plus ipilimumab |
| title_short | Editorial Comment to Expression of tertiary lymphoid structure in deferred cytoreductive nephrectomy of metastatic renal cell carcinoma treated with nivolumab plus ipilimumab |
| title_sort | editorial comment to expression of tertiary lymphoid structure in deferred cytoreductive nephrectomy of metastatic renal cell carcinoma treated with nivolumab plus ipilimumab |
| topic | Editorial Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560440/ https://www.ncbi.nlm.nih.gov/pubmed/34755055 http://dx.doi.org/10.1002/iju5.12360 |
| work_keys_str_mv | AT yuasatakeshi editorialcommenttoexpressionoftertiarylymphoidstructureindeferredcytoreductivenephrectomyofmetastaticrenalcellcarcinomatreatedwithnivolumabplusipilimumab |